1. Home
  2. BLTE vs INTR Comparison

BLTE vs INTR Comparison

Compare BLTE & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • INTR
  • Stock Information
  • Founded
  • BLTE 2018
  • INTR 1994
  • Country
  • BLTE United States
  • INTR Brazil
  • Employees
  • BLTE N/A
  • INTR N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • INTR
  • Sector
  • BLTE Health Care
  • INTR
  • Exchange
  • BLTE Nasdaq
  • INTR Nasdaq
  • Market Cap
  • BLTE 1.9B
  • INTR 2.5B
  • IPO Year
  • BLTE 2022
  • INTR N/A
  • Fundamental
  • Price
  • BLTE $61.10
  • INTR $7.14
  • Analyst Decision
  • BLTE Strong Buy
  • INTR Buy
  • Analyst Count
  • BLTE 4
  • INTR 4
  • Target Price
  • BLTE $96.67
  • INTR $6.48
  • AVG Volume (30 Days)
  • BLTE 29.7K
  • INTR 2.2M
  • Earning Date
  • BLTE 05-14-2025
  • INTR 05-16-2025
  • Dividend Yield
  • BLTE N/A
  • INTR 1.13%
  • EPS Growth
  • BLTE N/A
  • INTR 176.00
  • EPS
  • BLTE N/A
  • INTR 0.33
  • Revenue
  • BLTE N/A
  • INTR $743,862,312.00
  • Revenue This Year
  • BLTE N/A
  • INTR $84.15
  • Revenue Next Year
  • BLTE N/A
  • INTR $15.63
  • P/E Ratio
  • BLTE N/A
  • INTR $21.12
  • Revenue Growth
  • BLTE N/A
  • INTR 43.28
  • 52 Week Low
  • BLTE $40.00
  • INTR $3.88
  • 52 Week High
  • BLTE $86.53
  • INTR $7.84
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 51.45
  • INTR 74.24
  • Support Level
  • BLTE $59.04
  • INTR $6.34
  • Resistance Level
  • BLTE $62.55
  • INTR $7.20
  • Average True Range (ATR)
  • BLTE 2.51
  • INTR 0.23
  • MACD
  • BLTE 0.32
  • INTR 0.05
  • Stochastic Oscillator
  • BLTE 74.06
  • INTR 89.24

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About INTR Inter & Co. Inc.

Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.

Share on Social Networks: